AI assistant
Sending…
Tempest Therapeutics, Inc. — Director's Dealing 2021
Jun 30, 2021
34632_dirs_2021-06-29_3ae8bc8b-c869-4f57-b92a-0e4efaa22e6c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Millendo Therapeutics, Inc. (TPST)
CIK: 0001544227
Period of Report: 2021-06-25
Reporting Person: Xu Stella (N/A)
More from Tempest Therapeutics, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 30